ArticleQuantitative imaging in medicine and surgery2025
Incremental prognostic value of computed tomography-determined mitral annular dilatation in patients with severe aortic regurgitation undergoing transcatheter aortic valve replacement: a retrospective cohort study.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is little data about the prognostic value of mitral annular dilatation (MAD) in patients with symptomatic severe aortic regurgitation (AR) undergoing transcatheter aortic valve replacement (TAVR). This study aimed to assess the prognosis value of computed tomography (CT)-determined MAD in such patients. Methods: Consecutive patients with symptomatic severe AR who underwent pre-TAVR CT between May 2014 and May 2023 were included in this study. The clinical endpoint was the composite outcome of all-cause death and heart-failure hospitalization. Mitral annular dimensions were systematically measured by CT. A receiver operating characteristic (ROC) curve analysis was performed to obtain an ideal body surface area standardized cut-off value for MAD. A Cox regression analysis was performed to examine the association between MAD and composite outcomes. The incremental prognostic value of MAD was evaluated by calculating the net reclassification improvement and the integrated discrimination improvement. Results: Among the 281 patients (72.6±7.5 years, 33.1% female), 41 (14.6%) reached the clinical endpoint during a median follow-up period of 2.0 years. MAD was identified in 132 (47.0%) patients based on a ROC cut-off value of 71.3 mm/m Conclusions: MAD was an independent predictor of adverse outcomes after TAVR in patients with severe AR, and added incremental prognostic value to a baseline model composed of clinical and echocardiographic characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.